Media reports ignore that Global Fund resources deliver tremendous results in the fight against AIDS

February 07, 2011

February 7, 2011 - Geneva, Switzerland. Following the publication of several media reports which seriously distort the extent of fraud discovered in grants financed by the Global Fund to Fight AIDS, TB and Malaria, the International AIDS Society (IAS) urges all donors and governments to continue their funding.

The Global Fund is a unique and innovative financing instrument which attracts, manages and disburses resources to prevent and treat HIV/AIDS, tuberculosis and malaria. The fund is the most effective mechanism through which to disburse large amounts of resources rapidly and is credited with saving millions of lives. It is recognized as such by the international community. When the Global Fund was first created in 2002, only 40,000 people living with HIV in low and middle-income countries were receiving life saving anti-retroviral drugs. By December 2009, Global Fund-supported programmes were providing antiretroviral therapy to 2.5 million individuals in 104 low and middle-income countries, and the Global Fund Board had approved proposals totaling USD 19.2 billion and disbursed over USD 10 billion for HIV, TB and malaria control efforts to over 140 countries.

A distinguishing feature of the Global Fund is its strict and transparent auditing system, and its openness when it uncovers corruption. "Last week's reports on this subject contained no real news, and only referred to the Global Fund's own published audits which openly acknowledged that sums of money had been misappropriated," commented Julio Montaner, IAS Past President. "It would be a bitter irony if the Global Fund loses funding because of these reports, only for the same resources to be directed towards other multinational aids agencies who face the same challenges when it comes to fraud, but who may not be as transparent in their reporting. "

"All fraud is unacceptable and international financing mechanisms such as the Global Fund must work rigorously to ensure that funds are not misappropriated," said Prof. Françoise Barré-Sinoussi, International AIDS Society (IAS) President-elect and 2008 Nobel Laureate for Medicine. "But we must keep in mind that the Global Fund is known for consistently taking strong and firm action to recover losses whenever they are discovered." Indeed, the amount of money misspent represents less than 0.3 per cent of the total amount disbursed to countries by the Global Fund so far. Of each 100 US dollars disbursed by the Fund, 30 cents only have been misused, and 99.7 dollars have been used the right way, saving lives and increasing access to efficient treatments. Examples exist to show that the Fund has acted promptly and firmly and suspended further granting to governments found to have misused funds.

"The misuse of small fractions of Global Fund grants, while extremely serious, must be put into perspective and examined within the context of the complex challenges and emergencies that all international organizations face when dispersing large amounts of resources," said Elly Katabira, IAS President. "Withdrawing donations and freezing funding to the Global Fund will not only condemn millions of people who are not involved in the corruption to terrible fates, but will also send the dangerous message that organizations aiming to achieve best practice in transparency and accountability will be punished. The Global Fund should be supported and empowered to continue its work, not condemned for its efforts to root out corruption and improve its results."
-end-
About the IAS

The International AIDS Society (IAS) is the world's leading independent association of HIV professionals, with over 16,000 members from more than 196 countries working at all levels of the global response to AIDS. Our members include researchers from all disciplines, clinicians, public health and community practitioners on the frontlines of the epidemic, as well as policy and programme planners. The IAS is the custodian of the biennial International AIDS Conference and lead organizer of the IAS Conference on HIV Pathogenesis, Treatment and Prevention, which will be held in Rome, Italy in July 2011.

www.iasociety.org | www.ias2011.org

International AIDS Society

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.